Balyasny Asset Management LLC Ionis Pharmaceuticals Inc Put Options Transaction History

Balyasny Asset Management LLC

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 May 16, 2022	SELL	$29.88 - $37.04 $7.84 Million - $9.72 Million	-262,500 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$25.61 - $35.1 $2.88 Million - $3.95 Million	112,500 Added 75.0%	262,500 $7.99 Million
Q3 2021 Nov 15, 2021	BUY	$33.54 - $40.55 $5.03 Million - $6.08 Million	150,000 New	150,000 $5.03 Million
Q4 2018 Feb 14, 2019	SELL	$43.37 - $59.54 $2.47 Million - $3.39 Million	-57,000 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$42.88 - $53.7 $2.44 Million - $3.06 Million	57,000 New	57,000 $2.85 Million
Q1 2018 May 15, 2018	SELL	$44.08 - $55.05 $11 Million - $13.8 Million	-250,000 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$50.3 - $64.39 $2.52 Million - $3.22 Million	50,000 Added 25.0%	250,000 $12.6 Million
Q3 2017 Nov 14, 2017	BUY	$45.56 - $59.57 $9.11 Million - $11.9 Million	200,000	200,000 $10.1 Million

389

125M

2.25M

510K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.64B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.